{
    "2018-04-17": [
        [
            {
                "time": "",
                "original_text": "[推荐评级]医药行业周报：理性解读政策 继续看好Q2行情",
                "features": {
                    "keywords": [
                        "医药行业",
                        "政策",
                        "Q2行情"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[领先大市-B评级]医药行业周度报告：“互联网+医疗健康”获肯定 抗癌药零关税成定局",
                "features": {
                    "keywords": [
                        "互联网+医疗健康",
                        "抗癌药",
                        "零关税"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[看好评级]医药生物行业2018年一季报业绩前瞻：稳健增长 分化明显 重点关注意优质成长与稳健价值",
                "features": {
                    "keywords": [
                        "医药生物",
                        "一季报",
                        "稳健增长",
                        "优质成长",
                        "稳健价值"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "大盘重挫后市怎么办 三优势下10只龙头股续涨概率高",
                "features": {
                    "keywords": [
                        "大盘重挫",
                        "龙头股",
                        "续涨概率"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报:持续推荐创新药和医药商业",
                "features": {
                    "keywords": [
                        "医药生物",
                        "创新药",
                        "医药商业"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}